Public Board of Directors papers 27-10-22

Agenda item: 35/22d

Meeting of the Board of Directors Thursday 27 th October 2022

Subject / Title

Trust 5 year Strategy refresh

Author(s)

Neil Bayman, Executive Medical Director

Presented by

Neil Bayman, Executive Medical Director

This paper provides an overview of the process for the Christie Strategy refresh, including milestones and engagement points to date and next steps

Summary / purpose of paper

Recommendation(s)

The Board are asked to note the update and timeframes.

th October

Presentations to Board of Directors Time Out 7

Background papers

2022

Risk score

See BAF risks.

Link to:  Trust strategy  Corporate objectives

Trust Strategy 2018 – 2023 All corporate objectives (1-8)

R&I Research & Innovation CAG Clinical Advisory Group DG disease group AMD Associate Medical Director CD Clinical Director CRSC Christie Research Strategy Committee

You are reminded not to use acronyms or abbreviations wherever possible. However, if they appear in the attached paper, please list them in the adjacent box.

83